Re: Buy-Out
|
3
|
Resverlogix Corp.
|
Nov 21, 2019 04:46PM
|
Exempt Distributions - Dec 9, 2022 & Jan 13, 2023
|
3
|
Zenith Epigenetics
|
Jan 18, 2023 04:54PM
|
Re: IR
|
3
|
Resverlogix Corp.
|
Jan 14, 2023 10:08AM
|
Re: BTD
|
3
|
Resverlogix Corp.
|
Apr 25, 2022 07:36AM
|
Re: OTC Short interest up 0.88%/around 7k shrs to 767,637 as of the end of Feb
|
3
|
Resverlogix Corp.
|
Mar 11, 2022 04:38PM
|
Re: realisticly how long do they even have to try & close this "purposed offering" 4-6 weeks max?
|
3
|
Resverlogix Corp.
|
May 15, 2019 10:11AM
|
Re: Win or lose....one thing we know for sure
|
3
|
Resverlogix Corp.
|
Aug 31, 2019 01:27PM
|
Re: Warrants conversion!
|
3
|
Resverlogix Corp.
|
Nov 26, 2019 10:17AM
|
Re: May thru October 2020
|
3
|
Resverlogix Corp.
|
Apr 21, 2020 10:44AM
|
Re: DM conflict of interest
|
3
|
Resverlogix Corp.
|
Nov 12, 2023 09:25AM
|
Re: Led Gac
|
3
|
Resverlogix Corp.
|
Jun 08, 2020 05:46PM
|
Re: you won’t see anyone buying this
|
3
|
Zenith Epigenetics
|
Dec 07, 2023 06:54PM
|
Re: April Fools
|
3
|
Resverlogix Corp.
|
Apr 01, 2024 12:55PM
|
Re: Deja Vu All Over Again
|
3
|
Resverlogix Corp.
|
Mar 11, 2022 04:57PM
|
Re: Address your Shareholders Donald J. McCaffrey
|
3
|
Resverlogix Corp.
|
May 13, 2020 03:49PM
|
Re: buy on rumour sell on news?
|
3
|
Resverlogix Corp.
|
Mar 01, 2021 10:14AM
|
Re: No news
|
3
|
Resverlogix Corp.
|
Sep 17, 2022 09:14AM
|
Re: Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research
|
3
|
Resverlogix Corp.
|
Mar 23, 2020 09:56AM
|
Re: We need news on the status of the Third Eye loan....
|
3
|
Resverlogix Corp.
|
Jan 31, 2019 07:21PM
|
Re: BTD
|
3
|
Resverlogix Corp.
|
Apr 25, 2022 08:52AM
|